# A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer

> **NCT00352690** · PHASE2 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 10 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Paclitaxel poliglumex
- **DRUG:** Carboplatin
- **RADIATION:** External beam radiation therapy

## Key facts

- **NCT ID:** NCT00352690
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-04
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Safety of patients
- **Last updated:** 2016-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00352690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00352690, "A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00352690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*